We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AWH market cap is 13.48M. The company's latest EPS is USD -1.0014 and P/E is -3.99.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.49M | 2.22M | 2.13M | 2.15M | 2.42M |
Operating Income | -4.32M | -4.63M | -4.14M | -4.71M | -4.39M |
Net Income | -2.32M | -5.22M | -3.09M | -4.63M | -3.53M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 4.54M | 4.65M | 6.81M | 8.18M | 9.15M |
Operating Income | -15.28M | -17.98M | -32.6M | -32.77M | -18.85M |
Net Income | -15.24M | -17.91M | -31.66M | -27.17M | -16.69M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 7.72M | 8.66M | 6.26M | 7.16M | 3.96M |
Total Liabilities | 8.25M | 9.32M | 8.63M | 8.53M | 7.67M |
Total Equity | -528k | -659k | -2.37M | -1.36M | -3.71M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 13.83M | 19.61M | 41.08M | 17.37M | 6.26M |
Total Liabilities | 5.09M | 9.89M | 10.91M | 10.64M | 8.63M |
Total Equity | 8.74M | 9.72M | 30.17M | 6.73M | -2.37M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -9.12M | -12.44M | -15.89M | -4.43M | -8.17M |
Investing | -12k | -12k | -24k | -20k | -35k |
Financing | 79k | 4.26M | 5.22M | 5.27M | 6.31M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -12.97M | -14.73M | -27.4M | -32.19M | -15.89M |
Investing | -132k | -490k | -184k | -232k | -24k |
Financing | 15.44M | 20.15M | 48.38M | 8.54M | 5.22M |
Market Cap | 13.48M |
Price to Earnings Ratio | -3.99 |
Price to Sales Ratio | 7.28 |
Price to Cash Ratio | 25.67 |
Price to Book Ratio | -28.19 |
Dividend Yield | - |
Shares Outstanding | 16.67M |
Average Volume (1 week) | 90.4k |
Average Volume (1 Month) | 82.05k |
52 Week Change | -68.90% |
52 Week High | 5.65 |
52 Week Low | 0.6679 |
Spread (Intraday) | 0.25 (25.75%) |
Company Name | Aspira Womans Health Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://aspirawh.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions